0 results available. Select is focused ,type to refine list, press Down to open the menu,
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s product pipeline comprises ED...
The following section summarizes insights on Enanta Pharmaceuticals Inc's Quick Ratio:
We've identified the following companies as similar to Enanta Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Quick Ratio in the risk category include:
A ratio used to assess a company's short-term liquidity.
Quick Ratio or acid-test or liquidity ratio measures the ability of a company to use its near cash or quick assets to extinguish or retire its current liabilities immediately. Quick Ratio is defined as:
(Cash & ST Investments
(+) Accounts Receivable)
(/) Current Liabilities
(=) Quick Ratio
Quick Ratio for Enanta Pharmaceuticals is calculated as follows:
(Cash & ST Investments [ 216.7 M ]
(+) Accounts Receivable [ 7.718 M ]
(/) Current Liabilities [ 49.05 M ]
(=) Quick Ratio [ 4.6x ]
The tables below summarizes the trend in Enanta Pharmaceuticals’s quick ratio over the last five years:
| Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
|---|---|---|---|---|
| 2020-09-30 | 386.6 M | 23.492 M | 24.157 M | 17.0x |
| 2021-09-30 | 244 M | 23.576 M | 36.172 M | 7.4x |
| 2022-09-30 | 249.2 M | 20.318 M | 29.827 M | 9.0x |
| 2023-09-30 | 369.9 M | 8.614 M | 62.787 M | 6.0x |
| 2024-09-30 | 248.2 M | 6.646 M | 57.535 M | 4.4x |
The tables below summarizes the trend in Enanta Pharmaceuticals’s quick ratio over the last four quarters:
| Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
|---|---|---|---|---|
| 2024-03-31 | 300.3 M | 7.756 M | 54.608 M | 5.6x |
| 2024-06-30 | 230.1 M | 8.176 M | 58.231 M | 4.1x |
| 2024-09-30 | 248.2 M | 6.646 M | 57.535 M | 4.4x |
| 2024-12-31 | 216.7 M | 7.718 M | 49.05 M | 4.6x |
Read more on Wikipedia: Quick Ratio
The chart above depicts the distribution of quick ratio for companies operating in the Healthcare sector in the Developed economic region. Over 2,420 companies were considered in this analysis, and 2,328 had meaningful values. The average quick ratio of companies in the sector is 3.2x with a standard deviation of 4.2x.
Enanta Pharmaceuticals Inc's Quick Ratio of 4.6x ranks in the 78.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,426 |
| Included Constituents | 2,328 |
| Min | 0.0x |
| Max | 23.2x |
| Median | 1.5x |
| Mean | 3.2x |
| Standard Deviation | 4.2x |
You can find companies with similar quick ratio using this stock screener.